Forte Biosciences Stock Probability of Future Stock Price Finishing Under 7.98

FBRX Stock  USD 18.96  4.19  18.10%   
Forte Biosciences' future price is the expected price of Forte Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Forte Biosciences performance during a given time horizon utilizing its historical volatility. Check out Forte Biosciences Backtesting, Forte Biosciences Valuation, Forte Biosciences Correlation, Forte Biosciences Hype Analysis, Forte Biosciences Volatility, Forte Biosciences History as well as Forte Biosciences Performance.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.
  
Price To Sales Ratio is likely to drop to 9.98 in 2024. Price Earnings Ratio is likely to drop to -0.87 in 2024. Please specify Forte Biosciences' target price for which you would like Forte Biosciences odds to be computed.

Forte Biosciences Target Price Odds to finish below 7.98

The tendency of Forte Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 7.98  or more in 90 days
 18.96 90 days 7.98 
about 40.91
Based on a normal probability distribution, the odds of Forte Biosciences to drop to $ 7.98  or more in 90 days from now is about 40.91 (This Forte Biosciences probability density function shows the probability of Forte Stock to fall within a particular range of prices over 90 days) . Probability of Forte Biosciences price to stay between $ 7.98  and its current price of $18.96 at the end of the 90-day period is about 48.56 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.53 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Forte Biosciences will likely underperform. In addition to that Forte Biosciences has an alpha of 2.195, implying that it can generate a 2.19 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Forte Biosciences Price Density   
       Price  

Predictive Modules for Forte Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Forte Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
3.9120.8737.83
Details
Intrinsic
Valuation
LowRealHigh
0.5410.7527.71
Details
2 Analysts
Consensus
LowTargetHigh
3.193.503.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-4.97-3.7-2.43
Details

Forte Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Forte Biosciences is not an exception. The market had few large corrections towards the Forte Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Forte Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Forte Biosciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
2.19
β
Beta against Dow Jones1.53
σ
Overall volatility
7.40
Ir
Information ratio 0.13

Forte Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Forte Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Forte Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Forte Biosciences is way too risky over 90 days horizon
Forte Biosciences appears to be risky and price may revert if volatility continues
Forte Biosciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (31.48 M) with profit before overhead, payroll, taxes, and interest of 0.
Forte Biosciences currently holds about 38.55 M in cash with (28.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.89.
Forte Biosciences has a poor financial position based on the latest SEC disclosures
Latest headline from seekingalpha.com: Forte Biosciences files for secondary offering of common stock

Forte Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Forte Stock often depends not only on the future outlook of the current and potential Forte Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Forte Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.3 M
Cash And Short Term Investments37.1 M

Forte Biosciences Technical Analysis

Forte Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Forte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Forte Biosciences. In general, you should focus on analyzing Forte Stock price patterns and their correlations with different microeconomic environments and drivers.

Forte Biosciences Predictive Forecast Models

Forte Biosciences' time-series forecasting models is one of many Forte Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Forte Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Forte Biosciences

Checking the ongoing alerts about Forte Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Forte Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Forte Biosciences is way too risky over 90 days horizon
Forte Biosciences appears to be risky and price may revert if volatility continues
Forte Biosciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (31.48 M) with profit before overhead, payroll, taxes, and interest of 0.
Forte Biosciences currently holds about 38.55 M in cash with (28.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.89.
Forte Biosciences has a poor financial position based on the latest SEC disclosures
Latest headline from seekingalpha.com: Forte Biosciences files for secondary offering of common stock

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.